These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol. Arslan S, Erol MK, Bozkurt E, Acikel M, Gundogdu F, Atesal S, Senocak H. Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429 [Abstract] [Full Text] [Related]
24. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study. Hori M, Nagai R, Izumi T, Matsuzaki M. Heart Vessels; 2014 Mar; 29(2):238-47. PubMed ID: 23559359 [Abstract] [Full Text] [Related]
29. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases. Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N. J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774 [Abstract] [Full Text] [Related]
31. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure]. Wang F, Li W, Huang J, Wang L, Bian WY, Pang HM, Wang Y, Xu ZM, Li YS. Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545 [Abstract] [Full Text] [Related]
32. Prognostic value of plasma renin activity in heart failure. Vergaro G, Emdin M, Iervasi A, Zyw L, Gabutti A, Poletti R, Mammini C, Giannoni A, Fontana M, Passino C. Am J Cardiol; 2011 Jul 15; 108(2):246-51. PubMed ID: 21545993 [Abstract] [Full Text] [Related]
33. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ. J Card Fail; 2000 Jun 15; 6(2):130-9. PubMed ID: 10908087 [Abstract] [Full Text] [Related]
35. Brain natriuretic peptide response is heterogeneous during beta-blocker therapy for congestive heart failure. Yoshizawa A, Yoshikawa T, Nakamura I, Satoh T, Moritani K, Suzuki M, Baba A, Iwanaga S, Mitamura H, Ogawa S. J Card Fail; 2004 Aug 15; 10(4):310-5. PubMed ID: 15309697 [Abstract] [Full Text] [Related]
36. Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV. J Heart Lung Transplant; 2008 Nov 15; 27(11):1251-6. PubMed ID: 18971099 [Abstract] [Full Text] [Related]
37. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure. Aygul N, Ozdemir K, Duzenli MA, Aygul MU. Cardiology; 2009 Nov 15; 112(3):168-73. PubMed ID: 18654081 [Abstract] [Full Text] [Related]
38. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA. Circulation; 2004 Sep 28; 110(13):1780-6. PubMed ID: 15381643 [Abstract] [Full Text] [Related]